At M13, we focus on how emerging technologies will drive consumer behavior change, particularly behaviors that improve our daily lives. According to the Census Bureau, one-third of Americans currently suffer from stress, anxiety, or depression. But these are the official estimates. How many people go undiagnosed? How systemic are these issues? How many people turn to alcohol, painkillers, or their vape pen to help manage their stress? Without intervention and as the pandemic and other crises continue, so will substance abuse and overdoses and other devastating consequences. Mental well-being is an area we've been evaluating for some time, and last year we were very excited to meet Francois Kress and his team at Feelmore Labs who are building exciting, modern, and noninvasive solutions.
Based on breakthrough technology developed at MIT and Harvard’s joint medical program and after years of working in stealth mode in Brooklyn, Feelmore Labs is ready to launch its first product, Cove. In a nutshell: Cove uses cutting-edge, patented neuroscience technology to silently apply gentle vibrations behind the ears that initiate a natural biological pathway between the skin and the brain. By harnessing this connection, Cove is able to activate the part of the brain that regulates anxiety, leading to a profound and durable sense of calm.
Simply put it on for 20 minutes a day, without interruption to your day, on the way to work, before bed, while you enjoy your morning coffee. The device’s design is sleek, minimal and so subtle that it is almost unnoticeable. Cove will soon release software that allows you to personalize your experience and adjust the frequency to find your ideal wave.
We are huge fans of mindfulness and meditation but compliance is hard. Finding the time, space, and peace to meditate can often be a stress-inducing process. We believe that Feelmore is developing the evolution of these markets focused on passive use (i.e. easy compliance) and results. But Cove is just the first product; Feelmore has a very active pipeline across many mental health indications. Sleep is the next frontier and early indications are quite positive—just ask M13 Partner Christine Choi who says she has not slept this well since 2014!When evaluating investments based on new technology, we ask two questions:
The answer to both of these is a resounding yes. We tried the product, and it works.
We tried the product, and it works. Data across multiple studies have also proven its efficacy: in trial studies, 90% of subjects reported reduced stress and improved sleep after using Cove.
Cove launches this September, and we're thrilled to share this with the world. Please sign up here.
Congratulations to Francois and the whole team at Feelmore Labs on this exciting launch. We couldn’t be prouder to back you with our friends at True Ventures and Arch Ventures.
At M13, we focus on how emerging technologies will drive consumer behavior change, particularly behaviors that improve our daily lives. According to the Census Bureau, one-third of Americans currently suffer from stress, anxiety, or depression. But these are the official estimates. How many people go undiagnosed? How systemic are these issues? How many people turn to alcohol, painkillers, or their vape pen to help manage their stress? Without intervention and as the pandemic and other crises continue, so will substance abuse and overdoses and other devastating consequences. Mental well-being is an area we've been evaluating for some time, and last year we were very excited to meet Francois Kress and his team at Feelmore Labs who are building exciting, modern, and noninvasive solutions.
Based on breakthrough technology developed at MIT and Harvard’s joint medical program and after years of working in stealth mode in Brooklyn, Feelmore Labs is ready to launch its first product, Cove. In a nutshell: Cove uses cutting-edge, patented neuroscience technology to silently apply gentle vibrations behind the ears that initiate a natural biological pathway between the skin and the brain. By harnessing this connection, Cove is able to activate the part of the brain that regulates anxiety, leading to a profound and durable sense of calm.
Simply put it on for 20 minutes a day, without interruption to your day, on the way to work, before bed, while you enjoy your morning coffee. The device’s design is sleek, minimal and so subtle that it is almost unnoticeable. Cove will soon release software that allows you to personalize your experience and adjust the frequency to find your ideal wave.
We are huge fans of mindfulness and meditation but compliance is hard. Finding the time, space, and peace to meditate can often be a stress-inducing process. We believe that Feelmore is developing the evolution of these markets focused on passive use (i.e. easy compliance) and results. But Cove is just the first product; Feelmore has a very active pipeline across many mental health indications. Sleep is the next frontier and early indications are quite positive—just ask M13 Partner Christine Choi who says she has not slept this well since 2014!When evaluating investments based on new technology, we ask two questions:
The answer to both of these is a resounding yes. We tried the product, and it works.
We tried the product, and it works. Data across multiple studies have also proven its efficacy: in trial studies, 90% of subjects reported reduced stress and improved sleep after using Cove.
Cove launches this September, and we're thrilled to share this with the world. Please sign up here.
Congratulations to Francois and the whole team at Feelmore Labs on this exciting launch. We couldn’t be prouder to back you with our friends at True Ventures and Arch Ventures.
Read more
The views expressed here are those of the individual M13 personnel quoted and are not the views of M13 Holdings Company, LLC (“M13”) or its affiliates. This content is for general informational purposes only and does not and is not intended to constitute legal, business, investment, tax or other advice. You should consult your own advisers as to those matters and should not act or refrain from acting on the basis of this content. This content is not directed to any investors or potential investors, is not an offer or solicitation and may not be used or relied upon in connection with any offer or solicitation with respect to any current or future M13 investment partnership. Past performance is not indicative of future results. Unless otherwise noted, this content is intended to be current only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others. Any investments or portfolio companies mentioned, referred to, or described are not representative of all investments in funds managed by M13, and there can be no assurance that the investments will be profitable or that other investments made in the future will have similar characteristics or results. A list of investments made by funds managed by M13 is available at m13.co/portfolio.